An ongoing phase 2/3 clinical trial is also evaluating the interaction between the rs35652124 polymorphism in the NFE2L2 gene and curcumin supplementation on Nrf2 expression, oxidative stress, and renal function in early diabetic nephropathy patients (NCT03262363). Here, NFE2L2 is linked to diabetic kidney disease.